IL17A and cardiovascular disorder: Furthermore, this study will open a new avenue for the investigation of inflammatory mechanisms, not only in cardiovascular diseases such as HF and hypertension, but also in autoimmune diseases (e.g., multiple sclerosis) and neurodegenerative diseases (e.g., Parkinson’s disease), in which IL-17A is a critical contributor to the pathogenesis of the disease.